Drug recall · January 31, 2024
Benzonatate Capsules recall
Why: Superpotent drug: Assay results were slightly above specification at the time zero point.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11
- Lots / codes
Lot # 1014208, Exp Mar/31/2025
- Quantity
- 6,344 cartons
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- Nationwide in the USA
- Initiated
- December 26, 2023 · Voluntary: Firm initiated
- Classified
- January 19, 2024
- Reported
- January 31, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Benzonatate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.